SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Analyst Ratings
Europe - FRA:1SXP - DE000A3ENQ51 - Common Stock
19.42 EUR
+0.02 (+0.1%)
ChartMill assigns a Buy % Consensus number of 79% to 1SXP.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.13. This target is 55.15% above the current price.
1SXP.DE was analyzed by 19 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about 1SXP.DE.
In the previous month the buy percentage consensus was at a similar level.
1SXP.DE was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ
What do analysts expect the price target to be for SCHOTT PHARMA AG& CO KGAA (1SXP.DE)?
19 analysts have analysed 1SXP.DE and the average price target is 30.13 EUR. This implies a price increase of 55.15% is expected in the next year compared to the current price of 19.42.
What is the consensus rating for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock?
The consensus rating for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is 78.9474 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SCHOTT PHARMA AG& CO KGAA (1SXP.DE)?
The number of analysts covering SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is 19.